Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial thiol-containing enzymes are a diverse class of proteins that utilize the nucleophilic sulfhydryl (-SH) group of cysteine residues for catalytic activity, structural integrity, or redox regulation. These enzymes are essential for fundamental bacterial processes, including central metabolism (e.g., glyceraldehyde-3-phosphate dehydrogenase), cellular respiration (e.g., succinate dehydrogenase), and the maintenance of redox balance through systems like thioredoxin and glutathione. Furthermore, specific thiol-containing enzymes such as metallo-beta-lactamases (e.g., NDM-1) are major drivers of antibiotic resistance in Gram-negative pathogens by hydrolyzing carbapenems and other beta-lactam antibiotics. Due to the high affinity of thiols for soft metal ions and electrophiles, these enzymes are the primary targets for antimicrobial agents like silver ions, mercury-based compounds, and novel inhibitors like ebselen. Interaction with these agents typically results in the covalent modification of the active-site thiol, leading to irreversible enzyme inactivation, disruption of the respiratory chain, and the induction of lethal oxidative stress. However, therapeutic application is often limited by a lack of selectivity over human thiol-dependent enzymes and the potential for neutralization by host thiols in the systemic environment.
Covalent inhibition of sulfhydryl groups; Zinc chelation in metallo-beta-lactamases; Disruption of bacterial redox homeostasis; Inhibition of the respiratory chain; Induction of reactive oxygen species (ROS)
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial thiol-containing enzymes.